Insulin-like growth factor binding protein-3 (IGFBP-3) sensitivity and signalling in breast cancer
Insulin-like growth factor binding protein-3 (IGFBP-3) sensitivity and signalling in breast cancer
批准号:
nhmrc : 107244
负责人:
Dr Janet Martin
金额:
$27.63万
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2000
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2000-01-01 至 2002-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The growth of all tissues in the body depends on many growth factors, hormones and other proteins which work together to control cell division. Some of these factors stimulate the division of the cells which make up the body tissues, and some inhibit it, so that a balance of these stimulators and inhibitors ensures that tissues do not grow too fast, or too large. The development of breast cancer and the growth of breast tumours is thought to be due to uncontrolled or faulty actions of the proteins and hormones which regulate the way breast cells multiply. One protein which normally regulates the division of breast cells is IGFBP-3. We have found that in some breast cancer cells, IGFBP-3 is no longer able to inhibit cell division, and this may lead to tumour growth and invasion of other tissues. We are interested in finding out how IGFBP-3 normally controls breast cell proliferation, and why some breast cancers are resistant to IGFBP-3. To do this, we will use normal breast cells in culture to examine how IGFBP-3 interacts with other cellular factors to prevent cell division. We will then look at whether the breast cancer cells have changed so that they are no longer able to recognise IGFBP-3 as an inhibitory protein. This may be because of changes in the way IGFBP-3 binds to the breast cancer cell, or because of changes in the way it interacts with other proteins in the cell. Because IGFBP-3 is made by normal and breast cancer cells, we will also study whether the IGFBP-3 being made by breast cancer cells is normal, or if it changed in some way that makes it inactive. By understanding why some breast cancers are not inhibited by IGFBP-3, we will be able to design new and better methods of preventing, detecting and treating the growth of all breast tumours.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Endocrine and autocrine regulation of breast cancer cell growth by IGF binding protein-3 (IGFBP-3).
-
批准号:nhmrc : 302153
-
项目类别:NHMRC Project Grants
-
资助金额:$33.16万
-
财政年份:2004
-
负责人:Dr Janet Martin
-
依托单位:
国内基金
海外基金
登录
查看更多内容
BCL3介导前列腺癌Lum stem-like细胞干性维持与内分泌治疗抵抗的机制研究
-
批准号:2026JJ70013
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:汤谷雨
-
依托单位:
CDC like kinase 2调控巨噬细胞极化影响脓毒症肝损伤
-
批准号:2026JJ81104
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:王剑
-
依托单位:
桂花类胡萝卜素代谢相关新基因OfMYB-like的功能与机制解析
-
批准号:JCZRYB202501133
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
HmWER-like调控花青素影响绣球‘无尽夏’蓝色萼片形成的机制研究
-
批准号:2025JJ50137
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:彭继庆
-
依托单位:
OsbZIP60-like作为锌感受器调控香稻香味的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:包格根
-
依托单位:
MMRN1 通过 EGF-like 结构域参与白血病干细胞干性维持的作用机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2024
-
负责人:彭美茜
-
依托单位:
社区人群肠道定植肺炎克雷伯菌blaKPC-like
基因介导头孢他啶-阿维巴坦耐药分布及相关
机制研究
-
批准号:Q24H260012
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:李娅铃
-
依托单位:
NP63调控Basal-like亚型胰腺导管腺癌特异性增强子通过LAPT5/WWP2/MMC-I轴介导免疫逃逸的机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:邹晓平
-
依托单位:
SaCBL1-like–SaCIPK3-1分子模块提高马铃薯耐寒能力的功能和机理研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:30.0万元
-
批准年份:2024
-
负责人:陈琳
-
依托单位:
E3泛素连接酶MaXB3-like在乙烯诱导香蕉果实耐冷性中的机制分析
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:卫玮
-
依托单位: